CD40 Ligand antibody

Catalog No. ABIN7604335

The Rabbit Monoclonal anti-CD40 Ligand antibody has been validated for WB. It is suitable to detect CD40 Ligand in samples from Human and Mouse.

Quick Overview for CD40 Ligand antibody (ABIN7604335)

Target: CD40 Ligand (CD40LG)

Reactivity: Human, Mouse

Host: Rabbit

Clonality: Monoclonal

Conjugate: This CD40 Ligand antibody is un-conjugated

Application: Western Blotting (WB)

Clone: AAIE-3

Product Details anti-CD40 Ligand Antibody

Purpose: Anti-CD40L CD40LG Rabbit Monoclonal Antibody

Characteristics: Anti-CD40L CD40LG Rabbit Monoclonal Antibody (ABIN7604335). Tested in WB application. This antibody reacts with Human, Mouse.

Purification: Affinity-chromatography

Immunogen: A synthesized peptide derived from human CD40L

Isotype: IgG

Application Details

Application Notes: WB 1:500-1:2000

Restrictions: For Research Use only

Handling

Format: Liquid

Reconstitution: Restore with deionized water (or equivalent) for reconstitution volume of 1.0 mL

Concentration: Lot specific

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.

Target Details for CD40 Ligand

Target: CD40 Ligand (CD40LG)

Alternative Name: CD40LG

Background:

Synonyms: CD40 ligand,CD40-L,T-cell antigen Gp39,TNF-related activation protein,TRAP,Tumor necrosis factor ligand superfamily member 5,CD154,CD40 ligand, membrane form,CD40 ligand, soluble form,CD40LG,CD40L, TNFSF5, TRAP,

Tissue Specificity: Specifically expressed on activated CD4+ T- lymphocytes.

Molecular Weight: 85 kDa

UniProt: P29965

Pathways: NF-kappaB Signaling, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints